The accuracy of Ki67-trained PTM-NET in the segmentation of tumour and non-tumour regions in breast cancer tissues labelled with two other nuclear markers clinically relevant to breast cancer treatment, namely ER and PR, was assessed. The gene discussed is PGR; the disease is breast cancer.